1286932002: Oteracil potassium (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Orotate phosphoribosyltransferase inhibitor\Oteracil potassium

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\...

\Organic cyclic compound\Heterocyclic compound\Triazine derivative (substance)\Oteracil potassium

\Organic acid and/or organic acid derivative\Carboxylic acid and/or carboxylic acid derivative (substance)\Carboxylic acid anion (substance)\Monocarboxylate (substance)\Oteracil potassium

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

5256134010 Oteracil potassium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

5256135011 Oteracil potassium (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Oteracil potassium	Is a	Triazine derivative (substance)	true	Inferred relationship	Some
Oteracil potassium	Is a	Monocarboxylate (substance)	true	Inferred relationship	Some
Oteracil potassium	Is a	Orotate phosphoribosyltransferase inhibitor	true	Inferred relationship	Some
Oteracil potassium	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Orotate phosphoribosyltransferase inhibitor	true	Inferred relationship	Some
Oteracil potassium	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Oteracil	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Gimeracil 4.35 mg and oteracil (as oteracil potassium) 11.8 mg and tegafur 15 mg oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Oteracil potassium	Inferred relationship	Some	2
Product containing precisely gimeracil 5.8 milligram and oteracil (as oteracil potassium) 15.8 milligram and tegafur 20 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Oteracil potassium	Inferred relationship	Some	2

This concept is not in any reference sets